REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 719.40
Bid: 719.20
Ask: 719.40
Change: 6.80 (0.95%)
Spread: 0.20 (0.028%)
Open: 722.30
High: 724.40
Low: 718.10
Prev. Close: 712.60
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

14 Sep 2021 10:55

RNS Number : 7228L
SMBC Nikko Capital Markets Limited
14 September 2021
 

PRE-STABILISATION ANNOUNCEMENT

Date: 14 September 2021

Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.

HSBC Holdings plc

Pre - Stabilisation Notice

SMBC Nikko Capital Markets Limited ("SMBC Nikko") (contact: Steve Apted +44 20 3527 7442) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2014) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA").

The Securities:

 

Issuer:

HSBC Holdings plc

Guarantor (if any):

N/A

Aggregate Nominal Amount:

JPY (TBD)

Description:

JPY Notes due [03/2028]

Senior, Unsecured, Reg S

English Law

Listing: London Stock Exchange

 

ISIN: XS2387729408

 

Offer price:

100.00 per cent.

Other offer terms:

Denoms: JPY 100 million; Resettable

Stabilisation:

 

Stabilising manager(s):

SMBC Nikko (Stabilising Coordinator)

Daiwa Capital Markets Europe Limited

The Hongkong and Shanghai Banking Corporation Limited

Mizuho International plc

MUFG Securities EMEA plc

Nomura International plc

 

Stabilisation Period expected to start on:

14 September 2021

Stabilisation period expected to end no later than:

24 October 2021 (30 days after the proposed issue date of the securities)

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law.

Stabilisation trading venue:

London Stock Exchange (Main Market)

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time, but must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of the allotment of the securities. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not for distribution, directly or indirectly, in or into the United States or any other jurisdiction in which such distribution would be unlawful.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom ("UK") and persons in the UK who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with the Prospectus Regulation, as it forms part of domestic law by virtue of the EUWA (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

Singapore SFA Product Classification: The Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of the Securities and Futures Act (Chapter 289 of Singapore) (the "SFA"), that the securities are 'prescribed capital markets products' (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018).

This communication does not constitute any offering of the securities referenced or any securities in Japan. The securities referenced have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended, the "FIEA") and, accordingly, such securities referenced will not be offered or sold directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan or to others for re-offering or resale, directly or indirectly, in Japan or to any resident of Japan except pursuant to an exemption from the registration requirements of, and otherwise in compliance with the FIEA and other relevant laws and regulations of Japan. As used in this paragraph, "resident of Japan" means any person resident in Japan, including any corporation or other entity organised under the laws of Japan.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEANNLFSAFEEA
Date   Source Headline
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration
1st May 20244:00 pmRNSPublication of base prospectus supplement
30th Apr 20244:15 pmRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSHSBC Holdings 1Q 2024 webcast presentation
30th Apr 20247:00 amRNSRetirement of Group Chief Executive
30th Apr 20247:00 amRNSHSBC Holdings 1Q24 earnings release
29th Apr 20244:30 pmRNSTotal Voting Rights
29th Apr 20244:15 pmRNSDirector/PDMR Shareholding
23rd Apr 20246:04 pmRNSTransaction in Own Shares & Conclusion of Buy-Back
22nd Apr 20245:59 pmRNSTransaction in Own Shares
19th Apr 20245:57 pmRNSTransaction in Own Shares
19th Apr 20248:40 amRNSPost Stabilisation Notice
18th Apr 20245:58 pmRNSTransaction in Own Shares
18th Apr 202410:00 amRNSOverseas Regulatory Announcement - Board Meeting
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:24 pmRNSTransaction in Own Shares
15th Apr 20241:00 pmRNSFourth Interim Dividend for 2023 - Exchange Rate
12th Apr 20245:57 pmRNSTransaction in Own Shares
12th Apr 20243:35 pmRNSNotice of redemption
11th Apr 20246:25 pmRNSTransaction in Own Shares
11th Apr 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th Apr 20246:09 pmRNSTransaction in Own Shares
9th Apr 20245:53 pmRNSTransaction in Own Shares
9th Apr 20247:00 amRNSHSBC AGREES TO SELL ITS BUSINESS IN ARGENTINA
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities
19th Mar 20245:46 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.